Back to results
US 2010/0166860 A1Published application
Medicine for treating gastrointestinal disorder including acquired lactose-intolerance irritable bowel syndrome
OwnerJames E. Lundeen, SR.inventor
Life of this patent
Estimating the term…
Abstract
A method and a medicine for treating a human having a gastrointestinal disorder that includes acquired lactose-intolerance irritable bowel syndrome are provided. The method includes administering a dose of the medicine to the human. The medicine includes ducosate sodium, tolterodine salt and imipramine salt.
Claims9
A medicinal composition for treating a human having a gastrointestinal disorder comprising acquired lactose-intolerance irritable bowel syndrome, the composition comprising:
- imipramine salt 5 mg, Tolterodine salt 4 mg to 8 mg ducosate sodium 100 mg.
A treatment kit for a human having a gastrointestinal disorder comprising acquired lactose-intolerance irritable bowel syndrome, the kit comprising:
- a plurality of doses of a medicine, the medicine comprising:
- imipramine 5 mg, and tolterodine salt 4-8 mg and ducosate sodium 100 mg
Dependencies are inferred from the claim text.